实例探究 > Oxford Biomedica and Antha: Bioprocess Informatics to Accelerate Lentiviral Vector Process Development

Oxford Biomedica and Antha: Bioprocess Informatics to Accelerate Lentiviral Vector Process Development

公司规模
1,000+
地区
  • Europe
国家
  • United Kingdom
产品
  • LentiVector® platform
  • Antha platform
  • ambr®250 HT
  • Nova BioProfile® Flex2
  • QuantStudio™
技术栈
  • Cloud-based data store
  • Python-based environment
  • Machine Learning
  • Artificial Intelligence
实施规模
  • Enterprise-wide Deployment
影响指标
  • Cost Savings
  • Customer Satisfaction
  • Digital Expertise
  • Productivity Improvements
技术
  • 分析与建模 - 机器学习
  • 分析与建模 - 预测分析
  • 应用基础设施与中间件 - 数据交换与集成
  • 平台即服务 (PaaS) - 数据管理平台
适用行业
  • 生命科学
  • 药品
适用功能
  • 产品研发
  • 质量保证
用例
  • 机器状态监测
  • 质量预测分析
  • 过程控制与优化
服务
  • 数据科学服务
  • 软件设计与工程服务
  • 系统集成
关于客户
Oxford Biomedica is a leading company in lentiviral vector research, development, and manufacturing, with over 20 years of experience in gene and cell therapy. They were the first to treat humans with in vivo lentiviral-based vectors and have developed a valuable portfolio of gene and cell therapy product candidates for various medical indications. In 2017, they partnered with Synthace to use the Antha platform for automating and improving their bioprocess research and development.
挑战
Oxford Biomedica faced challenges in handling the large volume of bioprocessing data generated from their lentiviral vector development process. The traditional methods of using spreadsheets and proprietary vendor software tools were cumbersome, resource-intensive, and prone to bias. The need for a scalable, flexible, and robust software tool to automate complex experiments and handle high-volume data streams was evident.
解决方案
Oxford Biomedica implemented Synthace’s Antha platform to automate the upload, collation, organization, structuring, processing, visualization, and analysis of high-volume, high-density data streams. Antha provided a cloud-based data store and a Python-based environment for dynamic data interrogation. The platform enabled rapid organization and structuring of data from various sources, improved data integrity, and facilitated flexible analysis and visualization. This integration allowed Oxford Biomedica to handle the entire dataset, leading to better process characterization and understanding.
运营影响
  • Antha reduced the time from data generation to data interpretation from days to hours, achieving a ~94% resource saving for a typical process analysis.
  • The platform improved data integrity and reduced handling issues by automating data upload and structuring, eliminating manual touchpoints.
  • Antha enabled the use of the entire dataset, reducing bias and improving process characterization and understanding.
  • The platform provided a dynamic visualization environment, allowing flexible analysis and rapid access to process insights.
  • Antha facilitated collaborative development by enabling simultaneous data exploration by multiple users, enhancing efficiency and decision-making.
数量效益
  • Antha reduced the time spent uploading data from disparate sources by 83%.
  • The time required to structure data was reduced by 92%.
  • Overall, there was a 90% saving in time spent from generating raw data to creating a structured dataset (from 2.5 to 0.25 hours).
  • The time required to visualize data was reduced by over 80% (from 1.5 to 0.25 hours for a single offline analysis and from 2.25 to 0.35 hours for two offline analyses).
  • Antha achieved a ~94% reduction in resource demand from raw data to insight (from 10.75 to 0.6 hours) for a typical vector bioprocess development run.

Case Study missing?

Start adding your own!

Register with your work email and create a new case study profile for your business.

Add New Record

相关案例.

联系我们

欢迎与我们交流!
* Required
* Required
* Required
* Invalid email address
提交此表单,即表示您同意 IoT ONE 可以与您联系并分享洞察和营销信息。
不,谢谢,我不想收到来自 IoT ONE 的任何营销电子邮件。
提交

感谢您的信息!
我们会很快与你取得联系。